DELAWARE BIO'S
BOARD OF DIRECTORS
Delaware Bio’s board is dedicated to ensuring the success of the life science industry in the state of Delaware and the surrounding region. Ultimately, helping businesses not only survive but thrive driving innovation in the First State’s economy.
Chris Yochim
Chairman
Helen Stimson
CEO & President
Mike Bowman
Treasurer
Philip D. Amoa
Secretary
Izak Bahar
Vice President, R&D Assay Development
Siemens Healthineers
Mark T. Brainard, Ph.D.
President
Delaware Technical Community College
Richard Dashefsky
Senior Counsel
Christiana Care
Fran DiNuzzo
President & CEO
ILC Dover
Kristin Giffin
Vice President of Operations, Quality, and Support
Agilent Technologies
Ariel Gruswitz
Director of Innovation
Delaware Prosperity Partnership
Brian Haigh
Region Director
VWR
T. Ben Hsu, Ph.D., M.B.A
Chief Administrative Officer
QPS Holdings, LLC
Kelvin Lee, Ph.D.
Institute Director
Manufacturing USA National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL)
William Mongan
Vice President U.S. Business Development, New Product
Planning, and Foundations Brands
AstraZeneca Pharmaceuticals LP
Pamela Murphy
Vice President Investor Relations & Corporate Communications (ret)
Incyte Corporation
Jae Sly, PhD MBA
President
Strategic BioPharm Consulting, Inc.
Paula J. Swain
Executive Vice President of Human Resources
Incyte Corporation
Greg Tronto
Gore PharmBio Products Business Development Leader, Drug Delivery
W. L. Gore & Associates, Inc.
Ray Yin, Ph.D.
President
ANP Technologies, Inc.
Venu (Kal) Kalavacharla, Ph.D.
